SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-14-031551
Filing Date
2014-04-29
Accepted
2014-04-29 08:32:04
Documents
3
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a14-11201_110ka.htm 10-K/A 403398
2 EX-31.1 a14-11201_1ex31d1.htm EX-31.1 12716
3 EX-31.2 a14-11201_1ex31d2.htm EX-31.2 12739
  Complete submission text file 0001104659-14-031551.txt   430035
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52089 | Film No.: 14791392
SIC: 3841 Surgical & Medical Instruments & Apparatus